DA-007
- Generic Name
- DA-007
Clinical Study of DA-007 for the Treatment of Chemotherapy Induced Alopecia
Phase 3
Not yet recruiting
- Conditions
- Chemotherapy Induced AlopeciaChemotherapy Side Effects
- Interventions
- Drug: Placebo
- First Posted Date
- 2025-01-07
- Last Posted Date
- 2025-01-08
- Lead Sponsor
- Applied Biology, Inc.
- Target Recruit Count
- 140
- Registration Number
- NCT06762548
- Locations
- 🇮🇹
University of Rome ("G. Marconi"), Rome, Italy
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath